Molecular pathogenesis of spinocerebellar ataxia type 1 disease
- Authors
- Kang, Seongman; Hong, Sunghoi
- Issue Date
- Jun-2009
- Publisher
- KOREAN SOC MOLECULAR & CELLULAR BIOLOGY
- Keywords
- aggregates; ataxin-1; cell therapy; cellular dysfunction; polyglutamine; protein interaction
- Citation
- MOLECULES AND CELLS, v.27, no.6, pp.621 - 627
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- MOLECULES AND CELLS
- Volume
- 27
- Number
- 6
- Start Page
- 621
- End Page
- 627
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/119915
- DOI
- 10.1007/s10059-009-0095-y
- ISSN
- 1016-8478
- Abstract
- Spinocerebellar ataxia type 1 (SCA1) is an autosomal-dominant neurodegenerative disorder characterized by ataxia and progressive motor deterioration. SCA1 is associated with an elongated polyglutamine tract in ataxin-1, the SCA1 gene product. As summarized in this review, recent studies have clarified the molecular mechanisms of SCA1 pathogenesis and provided direction for future therapeutic approaches. The nucleus is the subcellular site where misfolded mutant ataxin-1 acts to cause SCA1 disease in the cerebellum. The role of these nuclear aggregates is the subject of intensive study. Additional proteins have been identified, whose conformational alterations occurring through interactions with the polyglutamine tract itself or non-polyglutamine regions in ataxin-1 are the cause of SCA-1 cytotoxicity. Therapeutic hope comes from the observations concerning the reduction of nuclear aggregation and alleviation of the pathogenic phenotype by the application of potent inhibitors and RNA interference.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 1. Journal Articles
- College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.